Curcumin, a polyphenolic compound derived from turmeric, has protective effects on myocardial injury through attenuation of oxidative stress and
inflammation.
Toll-like receptor 2 (TLR2), a key mediator of the innate immune system, is involved in
myocardial infarction and examined if controlled by
curcumin. Rat cardiomyocytes (CMs) were stimulated with
tumor necrosis factor (TNF)-α,
peptidoglycan (PGN) or
hypoxia/reoxygenation (H/R) with or without
curcumin pretreatment. Sprague-Dawley rats were fed
curcumin (300 mg/kg/day) 1 week before cardiac
ischemia/reperfusion (I/R) injury. The expression level of TLR2 and cardiac function were assessed. Both
mRNA and
protein of TLR2 were up-regulated in infarcted myocardium, while TLR4 remained unchanged. In CMs, TLR2 and
monocyte chemoattractant protein (MCP)-1 mRNAs were increased by TNF-α, PGN or H/R, whereas they were blunted by
curcumin. Immunofluorescence staining of CMs also showed that TLR2 and MCP-1 were increased after H/R, whereas
curcumin-pretreated CMs were not. In animal study, 2 weeks after I/R, TLR2 was increased in the
infarct zone, whereas it stayed unchanged in the Cur+I/R group. Macrophage infiltration (CD68), high-mobility group box 1 and
fibrosis were increased in the I/R group, whereas they were decreased in the Cur+I/R group.
Connexin 43 was reduced in the I/R group, while it recovered significantly in the Cur+I/R group. Cardiac contractility in the Cur+I/R group was also improved compared with that in the I/R group (max dp/dt in Cur+I/R group: 9660±612
vs. I/R group: 8119±366, P<.05). These results suggest that selective inhibition of TLR2 by
curcumin could be preventive and therapeutic for
myocardial infarction.